Divis Laboratories Ltd reported INR28.29 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q4 Mar/2026 27.69 25.21 24.90 May/23
FY2026Q3 Dec/2025 21.98 23.35 22.20 Feb/11
FY2026Q2 Sep/2025 25.97 24.74 19.20 Nov/07
FY2026Q1 Jun/2025 20.49 22.07 16.20 Aug/06
FY2025Q4 Mar/2025 24.90 20.67 20.30 May/17




Eps Change Date
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Aurobindo Pharma INR 15.86 0.19 Mar/2026
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Divis Laboratories Ltd INR 28.29 6.31 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Lupin INR 34.75 2.95 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Organon & Co USD 0.71 0.08 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026